Recent Price Movement and Market Context
On 18 Dec 2025, Entero Healthcare Solutions recorded a fresh 52-week low at Rs.969.05. This price level represents a notable drop from its 52-week high of Rs.1,564.95, indicating a substantial correction over the past year. The stock has been on a downward trajectory for three consecutive trading sessions, cumulatively returning -2.96% during this period. Today's performance also showed a decline of 1.30%, underperforming the Retailing sector by 1.58%.
In comparison, the broader market benchmark, the Sensex, opened flat but moved into negative territory, trading at 84,433.34 points, down 0.15% or 41.32 points. Despite this, the Sensex remains within 2.04% of its own 52-week high of 86,159.02 and is supported by bullish moving averages, with the 50-day moving average positioned above the 200-day moving average.
Technical Indicators and Moving Averages
Entero Healthcare Solutions is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning suggests a sustained downward pressure on the stock price over multiple time horizons. The consistent trading below these averages often signals a cautious market sentiment towards the stock.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Long-Term Performance and Comparative Analysis
Over the past year, Entero Healthcare Solutions has delivered a return of -33.77%, contrasting sharply with the Sensex’s positive return of 5.30% during the same period. This divergence highlights the stock’s relative underperformance within the broader market context. Additionally, the stock has lagged behind the BSE500 index over the last three years, one year, and three months, indicating a persistent trend of subdued returns relative to its peers.
The stock’s market capitalisation is graded at level 3, reflecting its mid-tier size within the Retailing sector. Despite the recent price weakness, the company’s valuation metrics suggest it is trading at a discount compared to the historical averages of its sector peers, with an enterprise value to capital employed ratio of 2.2.
Financial Health and Profitability Metrics
Entero Healthcare Solutions demonstrates a strong capacity to service its debt, with a Debt to EBITDA ratio of 1.33 times. This relatively low leverage ratio indicates manageable debt levels in relation to earnings before interest, taxes, depreciation, and amortisation.
The company has reported healthy long-term growth trends, with net sales expanding at an annual rate of 30.10% and operating profit increasing by 127.38%. These figures reflect a robust expansion in business scale and operational earnings over time.
Quarterly financial results have shown positive trends, with the latest quarter recording the highest figures to date in several key areas: profit after tax (PAT) at Rs.31.60 crores, net sales at Rs.1,570.95 crores, and profit before depreciation, interest, and taxes (PBDIT) at Rs.62.06 crores. These milestones indicate ongoing operational strength despite the stock’s price challenges.
Valuation and Return on Capital Employed
The company’s return on capital employed (ROCE) stands at 8.6%, which is considered attractive within its sector. This metric, combined with the valuation discount relative to peers, suggests that the stock’s current price may not fully reflect the underlying business fundamentals.
Over the past year, while the stock price has declined by 33.77%, the company’s profits have risen by 142%. This disparity between earnings growth and stock price performance is notable and is reflected in a price/earnings to growth (PEG) ratio of 0.3, indicating a low valuation relative to earnings growth.
Why settle for Entero Healthcare Solutions ? SwitchER evaluates this Retailing small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Institutional Holdings and Market Position
Institutional investors hold 24.32% of Entero Healthcare Solutions’ shares. This level of institutional ownership suggests that a significant portion of the stock is held by entities with extensive resources and analytical capabilities, which may influence trading dynamics and valuation perceptions.
Despite the recent price decline, the company’s consistent quarterly profitability over the last seven quarters underscores a stable earnings base. This consistency in results provides a foundation for the company’s financial profile amid fluctuating market conditions.
Summary of Key Price and Performance Metrics
To summarise, Entero Healthcare Solutions’ stock price has reached Rs.969.05, its lowest level in the past 52 weeks. The stock’s performance over the last year shows a return of -33.77%, contrasting with the Sensex’s positive 5.30% return. The stock trades below all major moving averages, signalling a cautious market stance. Meanwhile, the company’s financial indicators reveal strong sales growth, rising profits, manageable debt levels, and an attractive valuation relative to peers.
These factors collectively paint a complex picture of a company with solid underlying financials but facing headwinds in market valuation and stock price performance.
Only Rs. 14,999 - Get MojoOne + Stock of the Week for 1 Year PLUS 18 Months FREE! Start Saving Now →
